BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay

Anna Guerra, Vincenza Di Stasi, Pio Zeppa, Antongiulio Faggiano, Vincenzo Marotta, Mario Vitale

Research output: Contribution to journalArticle

Abstract

Detection of BRAF mutation in cytology specimens has been proposed as a diagnostic adjunctive tool in evaluation of thyroid nodules with indeterminate cytology findings. Concurrent papillary thyroid carcinoma and Hashimoto's thyroiditis (HT), a disease characterized by thyroid lymphocytic infiltration, is a frequent occurrence. A large lymphocytic infiltrate might reduce the sensitivity of methods employed to detect BRAF mutation in thyroid cytology specimens. To determine whether testing for BRAF mutational status in fine needle aspirates (FNA) is reliable also in the presence of HT lymphocytic infiltration, we assessed the BRAF status by direct sequencing and pyrosequencing in a series of FNAs with and without concomitant HT lymphocytic infiltration. We also performed the same assessment by pyrosequencing in the corresponding tissue samples. Pyrosequencing demonstrated to be more sensitive than direct sequencing. The percentage of mutant BRAF V600E alleles was higher in FNAs than in the corresponding tissues, probably because of the lower stromal contamination in FNA than in the sections. In the presence of lymphocytic infiltration, the percentage of mutant BRAF V600E alleles determined by pyrosequencing was higher in FNAs than in the corresponding tissue samples (P <0.0001), indicating a minor lymphocytic contamination in FNA. The diagnostic value of BRAF V600E in inconclusive FNAs was not hampered by thyroid lymphocytic infiltration. These results indicate that BRAF V600E assessment by pyrosequencing is a reliable assay useful to refine inconclusive cytology of thyroid nodules also in the presence of concurrent HT.

Original languageEnglish
Pages (from-to)249-255
Number of pages7
JournalEndocrine
Volume45
Issue number2
DOIs
Publication statusPublished - Mar 2014

Fingerprint

Hashimoto Disease
Thyroid Nodule
Needles
Cell Biology
Thyroid Gland
Alleles
Mutation
Thyroid Diseases

Keywords

  • BRAF mutation
  • FNAC
  • Hashimoto's thyroiditis
  • Papillary thyroid cancer
  • Pyrosequencing

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay. / Guerra, Anna; Di Stasi, Vincenza; Zeppa, Pio; Faggiano, Antongiulio; Marotta, Vincenzo; Vitale, Mario.

In: Endocrine, Vol. 45, No. 2, 03.2014, p. 249-255.

Research output: Contribution to journalArticle

Guerra, Anna ; Di Stasi, Vincenza ; Zeppa, Pio ; Faggiano, Antongiulio ; Marotta, Vincenzo ; Vitale, Mario. / BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay. In: Endocrine. 2014 ; Vol. 45, No. 2. pp. 249-255.
@article{8a65b3c7196f45f2821690777cec78fe,
title = "BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay",
abstract = "Detection of BRAF mutation in cytology specimens has been proposed as a diagnostic adjunctive tool in evaluation of thyroid nodules with indeterminate cytology findings. Concurrent papillary thyroid carcinoma and Hashimoto's thyroiditis (HT), a disease characterized by thyroid lymphocytic infiltration, is a frequent occurrence. A large lymphocytic infiltrate might reduce the sensitivity of methods employed to detect BRAF mutation in thyroid cytology specimens. To determine whether testing for BRAF mutational status in fine needle aspirates (FNA) is reliable also in the presence of HT lymphocytic infiltration, we assessed the BRAF status by direct sequencing and pyrosequencing in a series of FNAs with and without concomitant HT lymphocytic infiltration. We also performed the same assessment by pyrosequencing in the corresponding tissue samples. Pyrosequencing demonstrated to be more sensitive than direct sequencing. The percentage of mutant BRAF V600E alleles was higher in FNAs than in the corresponding tissues, probably because of the lower stromal contamination in FNA than in the sections. In the presence of lymphocytic infiltration, the percentage of mutant BRAF V600E alleles determined by pyrosequencing was higher in FNAs than in the corresponding tissue samples (P <0.0001), indicating a minor lymphocytic contamination in FNA. The diagnostic value of BRAF V600E in inconclusive FNAs was not hampered by thyroid lymphocytic infiltration. These results indicate that BRAF V600E assessment by pyrosequencing is a reliable assay useful to refine inconclusive cytology of thyroid nodules also in the presence of concurrent HT.",
keywords = "BRAF mutation, FNAC, Hashimoto's thyroiditis, Papillary thyroid cancer, Pyrosequencing",
author = "Anna Guerra and {Di Stasi}, Vincenza and Pio Zeppa and Antongiulio Faggiano and Vincenzo Marotta and Mario Vitale",
year = "2014",
month = "3",
doi = "10.1007/s12020-013-9994-y",
language = "English",
volume = "45",
pages = "249--255",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press Inc.",
number = "2",

}

TY - JOUR

T1 - BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay

AU - Guerra, Anna

AU - Di Stasi, Vincenza

AU - Zeppa, Pio

AU - Faggiano, Antongiulio

AU - Marotta, Vincenzo

AU - Vitale, Mario

PY - 2014/3

Y1 - 2014/3

N2 - Detection of BRAF mutation in cytology specimens has been proposed as a diagnostic adjunctive tool in evaluation of thyroid nodules with indeterminate cytology findings. Concurrent papillary thyroid carcinoma and Hashimoto's thyroiditis (HT), a disease characterized by thyroid lymphocytic infiltration, is a frequent occurrence. A large lymphocytic infiltrate might reduce the sensitivity of methods employed to detect BRAF mutation in thyroid cytology specimens. To determine whether testing for BRAF mutational status in fine needle aspirates (FNA) is reliable also in the presence of HT lymphocytic infiltration, we assessed the BRAF status by direct sequencing and pyrosequencing in a series of FNAs with and without concomitant HT lymphocytic infiltration. We also performed the same assessment by pyrosequencing in the corresponding tissue samples. Pyrosequencing demonstrated to be more sensitive than direct sequencing. The percentage of mutant BRAF V600E alleles was higher in FNAs than in the corresponding tissues, probably because of the lower stromal contamination in FNA than in the sections. In the presence of lymphocytic infiltration, the percentage of mutant BRAF V600E alleles determined by pyrosequencing was higher in FNAs than in the corresponding tissue samples (P <0.0001), indicating a minor lymphocytic contamination in FNA. The diagnostic value of BRAF V600E in inconclusive FNAs was not hampered by thyroid lymphocytic infiltration. These results indicate that BRAF V600E assessment by pyrosequencing is a reliable assay useful to refine inconclusive cytology of thyroid nodules also in the presence of concurrent HT.

AB - Detection of BRAF mutation in cytology specimens has been proposed as a diagnostic adjunctive tool in evaluation of thyroid nodules with indeterminate cytology findings. Concurrent papillary thyroid carcinoma and Hashimoto's thyroiditis (HT), a disease characterized by thyroid lymphocytic infiltration, is a frequent occurrence. A large lymphocytic infiltrate might reduce the sensitivity of methods employed to detect BRAF mutation in thyroid cytology specimens. To determine whether testing for BRAF mutational status in fine needle aspirates (FNA) is reliable also in the presence of HT lymphocytic infiltration, we assessed the BRAF status by direct sequencing and pyrosequencing in a series of FNAs with and without concomitant HT lymphocytic infiltration. We also performed the same assessment by pyrosequencing in the corresponding tissue samples. Pyrosequencing demonstrated to be more sensitive than direct sequencing. The percentage of mutant BRAF V600E alleles was higher in FNAs than in the corresponding tissues, probably because of the lower stromal contamination in FNA than in the sections. In the presence of lymphocytic infiltration, the percentage of mutant BRAF V600E alleles determined by pyrosequencing was higher in FNAs than in the corresponding tissue samples (P <0.0001), indicating a minor lymphocytic contamination in FNA. The diagnostic value of BRAF V600E in inconclusive FNAs was not hampered by thyroid lymphocytic infiltration. These results indicate that BRAF V600E assessment by pyrosequencing is a reliable assay useful to refine inconclusive cytology of thyroid nodules also in the presence of concurrent HT.

KW - BRAF mutation

KW - FNAC

KW - Hashimoto's thyroiditis

KW - Papillary thyroid cancer

KW - Pyrosequencing

UR - http://www.scopus.com/inward/record.url?scp=84896695321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896695321&partnerID=8YFLogxK

U2 - 10.1007/s12020-013-9994-y

DO - 10.1007/s12020-013-9994-y

M3 - Article

C2 - 23775008

AN - SCOPUS:84896695321

VL - 45

SP - 249

EP - 255

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 2

ER -